Story thread · 2 reports / 2 sources
Braveheart Bio, Attovia seek $275M and $182M in U.S. IPOs
seekingalpha.com · 12d
How the coverage leans
Across 2 sources · syndicated copies counted once
First report: Pfizer's Phase 3 win for Litfulo; Braveheart, Attovia eye IPOs of $275M, $182M — endpts.com, 12d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.